{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T16:46:08Z","timestamp":1791305168863,"version":"4.3.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,9]],"date-time":"2021-10-09T00:00:00Z","timestamp":1633737600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,10,9]],"date-time":"2021-10-09T00:00:00Z","timestamp":1633737600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Skeletal dysplasia is typically diagnosed using a combination of radiographic imaging, clinical examinations, and molecular testing. Identifying a molecular diagnosis for an individual with a skeletal dysplasia can lead to improved clinical care, guide future medical management and treatment, and inform assessment of risk for familial recurrence. The molecular diagnostic utility of multi-gene panel testing using next-generation sequencing (NGS) has not yet been characterized for an unselected population of individuals with suspected skeletal dysplasia. In this study, we retrospectively reviewed patient reports to assess the diagnostic yield, reported variant characteristics, impact of copy number variation, and performance in prenatal diagnostics of panel tests for variants in genes associated with skeletal dysplasia and growth disorders.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Clinical reports\u202fof\u202fconsecutive\u202fpatients\u202fwith a clinical indication of\u202fsuspected\u202fskeletal dysplasia\u202fwho underwent\u202fpanel testing\u202fwere examined. The 543 patients included in the study submitted samples for diagnostic genetic testing with an indication of suspected skeletal dysplasia or growth disorder and received one of three nested panel tests. A molecular diagnosis was established in 42.0% of patients (n\u2009=\u2009228\/543). Diagnostic variants were identified in 71 genes, nearly half of which (n\u2009=\u200935, 49.3%) contributed uniquely to a molecular diagnosis for a single patient in this cohort. Diagnostic yield was significantly higher among fetal samples (59.0%, n\u2009=\u200952\/88) than postnatal samples (38.7%, n\u2009=\u2009176\/455; z\u2009=\u20093.55,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). Diagnostic variants in fetal cases were identified across 18 genes. Thirteen diagnostic\u202fCNVs were reported, representing 5.7%\u202fof diagnostic findings and ranging in size from 241-bp\u202fto\u202fwhole chromosome aneuploidy. Additionally, 11.4% (36\/315) of non-diagnostic patient reports had suspicious variants of unknown significance (VUS), in which additional family studies that provide segregation data and\/or functional characterization may result in reclassification to likely pathogenic.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>These findings demonstrate the utility of panel testing for individuals with a suspected skeletal dysplasia or growth disorder, with a particularly high diagnostic yield seen in prenatal cases. Pursuing comprehensive panel testing with high-resolution CNV analysis can provide a diagnostic benefit, given the considerable phenotype overlap amongst skeletal dysplasia conditions.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13023-021-02025-7","type":"journal-article","created":{"date-parts":[[2021,10,10]],"date-time":"2021-10-10T15:35:43Z","timestamp":1633880143000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Diagnostic utility of next-generation sequencing-based panel testing in 543 patients with suspected skeletal dysplasia"],"prefix":"10.1186","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1974-6251","authenticated-orcid":false,"given":"Alicia","family":"Scocchia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiia","family":"Kangas-Kontio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melita","family":"Irving","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matti","family":"Hero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inka","family":"Saarinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liisa","family":"Pelttari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly","family":"Gall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satu","family":"Valo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna M.","family":"Huusko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonna","family":"Tallila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"Sistonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juha","family":"Koskenvuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tero-Pekka","family":"Alastalo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,9]]},"reference":[{"key":"2025_CR1","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.1002\/ajmg.a.61366","volume":"179","author":"GR Mortier","year":"2019","unstructured":"Mortier GR, Cohn DH, Cormier-Daire V, Hall C, Krakow D, Mundlos S, et al. Nosology and classification of genetic skeletal disorders: 2019 revision. Am J Med Genet A. 2019;179:2393\u2013419.","journal-title":"Am J Med Genet A"},{"key":"2025_CR2","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1002\/pd.5653","volume":"40","author":"J Han","year":"2020","unstructured":"Han J, Yang Y, He Y, Liu W, Zhen L, Pan M, et al. Rapid prenatal diagnosis of skeletal dysplasia using medical trio exome sequencing: benefit for prenatal counseling and pregnancy management. Prenatal Diag. 2020;40:577\u201384.","journal-title":"Prenatal Diag"},{"key":"2025_CR3","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.clp.2015.03.003","volume":"42","author":"D Krakow","year":"2015","unstructured":"Krakow D. Skeletal dysplasias. Clin Perinatol. 2015;42:301\u201319.","journal-title":"Clin Perinatol"},{"key":"2025_CR4","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1002\/pd.5501","volume":"39","author":"E Pajkrt","year":"2019","unstructured":"Pajkrt E, Chitty LS. A sonographic approach to the prenatal diagnosis of skeletal dysplasias. Prenatal Diag. 2019;39:701\u201319.","journal-title":"Prenatal Diag"},{"key":"2025_CR5","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/S2352-4642(20)30056-0","volume":"4","author":"AD Calder","year":"2020","unstructured":"Calder AD. The changing world of skeletal dysplasia. Lancet Child Adolesc Health. 2020;4:253\u20134.","journal-title":"Lancet Child Adolesc Health"},{"key":"2025_CR6","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1007\/s00247-019-04537-8","volume":"50","author":"LA Gilligan","year":"2020","unstructured":"Gilligan LA, Calvo-Garcia MA, Weaver KN, Kline-Fath BM. Fetal magnetic resonance imaging of skeletal dysplasias. Pediatr Radiol. 2020;50:224\u201333.","journal-title":"Pediatr Radiol"},{"key":"2025_CR7","doi-asserted-by":"crossref","unstructured":"Dwan K, Phillipi CA, Steiner RD, Basel D. Bisphosphonate therapy for osteogenesis imperfecta. Cochrane Database Syst Rev. 2016.","DOI":"10.1002\/14651858.CD005088.pub4"},{"key":"2025_CR8","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1038\/gim.2017.159","volume":"20","author":"NN Hauer","year":"2018","unstructured":"Hauer NN, Popp B, Schoeller E, Schuhmann S, Heath KE, Hisado-Oliva A, et al. Clinical relevance of systematic phenotyping and exome sequencing in patients with short stature. Genet Med. 2018;20:630\u20138.","journal-title":"Genet Med"},{"key":"2025_CR9","doi-asserted-by":"publisher","first-page":"204201882090401","DOI":"10.1177\/2042018820904016","volume":"11","author":"P Marzin","year":"2020","unstructured":"Marzin P, Cormier-Daire V. New perspectives on the treatment of skeletal dysplasia. Ther Adv Endocrinol Metab. 2020;11:2042018820904016.","journal-title":"Ther Adv Endocrinol Metab"},{"key":"2025_CR10","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1056\/NEJMoa1813446","volume":"381","author":"R Savarirayan","year":"2019","unstructured":"Savarirayan R, Irving M, Bacino CA, Bostwick B, Charrow J, Cormier-Daire V, et al. C-type natriuretic peptide analogue therapy in children with achondroplasia. New Engl J Med. 2019;381:25\u201335.","journal-title":"New Engl J Med"},{"key":"2025_CR11","doi-asserted-by":"publisher","first-page":"2975","DOI":"10.1007\/s00198-017-4141-x","volume":"28","author":"P Trejo","year":"2017","unstructured":"Trejo P, Palomo T, Montpetit K, Fassier F, Sato A, Glorieux FH, et al. Long-term follow-up in osteogenesis imperfecta type VI. Osteoporosis Int. 2017;28:2975\u201383.","journal-title":"Osteoporosis Int"},{"key":"2025_CR12","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.bone.2016.07.020","volume":"102","author":"F Falardeau","year":"2017","unstructured":"Falardeau F, Camurri MV, Campeau PM. Genomic approaches to diagnose rare bone disorders. Bone. 2017;102:5\u201314.","journal-title":"Bone"},{"key":"2025_CR13","doi-asserted-by":"publisher","first-page":"e0138314","DOI":"10.1371\/journal.pone.0138314","volume":"10","author":"DL Polla","year":"2015","unstructured":"Polla DL, Cardoso MTO, Silva MCB, Cardoso ICC, Medina CTN, Araujo R, et al. Use of targeted exome sequencing for molecular diagnosis of skeletal disorders. PLoS ONE. 2015;10:e0138314.","journal-title":"PLoS ONE"},{"key":"2025_CR14","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1002\/pd.5298","volume":"38","author":"X Zhou","year":"2018","unstructured":"Zhou X, Chandler N, Deng L, Zhou J, Yuan M, Sun L. Prenatal diagnosis of skeletal dysplasias using a targeted skeletal gene panel. Prenatal Diag. 2018;38:692\u20139.","journal-title":"Prenatal Diag"},{"key":"2025_CR15","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1002\/pd.5717","volume":"40","author":"C Deden","year":"2020","unstructured":"Deden C, Neveling K, Zafeiropopoulou D, Gilissen C, Pfundt R, Rinne T, et al. Rapid whole exome sequencing in pregnancies to identify the underlying genetic cause in fetuses with congenital anomalies detected by ultrasound imaging. Prenatal Diag. 2020;40:972\u201383.","journal-title":"Prenatal Diag"},{"key":"2025_CR16","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1038\/gim.2015.148","volume":"18","author":"K Retterer","year":"2016","unstructured":"Retterer K, Juusola J, Cho MT, Vitazka P, Millan F, Gibellini F, et al. Clinical application of whole-exome sequencing across clinical indications. Genet Med. 2016;18:696\u2013704.","journal-title":"Genet Med"},{"key":"2025_CR17","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s13000-019-0853-x","volume":"14","author":"Y Liu","year":"2019","unstructured":"Liu Y, Wang L, Yang YK, et al. Prenatal diagnosis of fetal skeletal dysplasia using targeted next-generation sequencing: an analysis of 30 cases. Diagn Pathol. 2019;14:76.","journal-title":"Diagn Pathol"},{"key":"2025_CR18","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s12920-021-00993-0","volume":"14","author":"AH Sabir","year":"2021","unstructured":"Sabir AH, Morley E, Sheikh J, et al. Diagnostic yield of rare skeletal dysplasia conditions in the radiogenomics era. BMC Med Genomics. 2021;14:148.","journal-title":"BMC Med Genomics"},{"key":"2025_CR19","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/s41439-020-00132-8","volume":"7","author":"N Uchida","year":"2020","unstructured":"Uchida N, Shibata H, Nishimura G, Hasegawa T. A novel mutation in the ACAN gene in a family with autosomal dominant short stature and intervertebral disc disease. Hum Genome Var. 2020;7:44.","journal-title":"Hum Genome Var"},{"key":"2025_CR20","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1038\/nbt.1996","volume":"29","author":"S Myllykangas","year":"2011","unstructured":"Myllykangas S, Buenrostro JD, Natsoulis G, Bell JM, Ji HP. Efficient targeted resequencing of human germline and cancer genomes by oligonucleotide-selective sequencing. Nat Biotechnol. 2011;29:1024\u20137.","journal-title":"Nat Biotechnol"},{"issue":"4","key":"2025_CR21","doi-asserted-by":"publisher","first-page":"e1004873","DOI":"10.1371\/journal.pcbi.1004873","volume":"12","author":"E Talevich","year":"2016","unstructured":"Talevich E, Shain AH, Botton T, Bastian BC. CNVkit: genome-wide copy number detection and visualization from targeted DNA sequencing. PLOS Comput Biol. 2016;12(4):e1004873.","journal-title":"PLOS Comput Biol"},{"key":"2025_CR22","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405\u201323.","journal-title":"Genet Med"}],"updated-by":[{"DOI":"10.1186\/s13023-022-02242-8","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2022,2,17]],"date-time":"2022-02-17T00:00:00Z","timestamp":1645056000000}}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-021-02025-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-021-02025-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-021-02025-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,18]],"date-time":"2022-02-18T02:15:19Z","timestamp":1645150519000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-021-02025-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,9]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2025"],"URL":"https:\/\/doi.org\/10.1186\/s13023-021-02025-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-726678\/v1","asserted-by":"object"}]},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,9]]},"assertion":[{"value":"16 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2022","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s13023-022-02242-8","URL":"https:\/\/doi.org\/10.1186\/s13023-022-02242-8","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed parental or personal consent for diagnostic genetic testing was obtained for all patients included in this study. This subsequent retrospective study of patient data was given the status of exempt by WCG Institutional Review Board.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"AS, TK, LP, KG, IS, SV, JMK, JT, JS, JK, and T-PA are employees of Blueprint Genetics. MH is a consultant for Blueprint Genetics. The remaining authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"412"}}